The estimated Net Worth of Lori M. Henderson is at least $596 mil dollars as of 27 May 2021. Ms. Henderson owns over 6,600 units of Moderna Inc stock worth over $596,405 and over the last 6 years she sold MRNA stock worth over $0. In addition, she makes $0 as General Counsel e Company Secretary at Moderna Inc.
Lori has made over 29 trades of the Moderna Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 6,600 units of MRNA stock worth $98,010 on 27 May 2021.
The largest trade she's ever made was exercising 64,000 units of Moderna Inc stock on 18 June 2020 worth over $950,400. On average, Lori trades about 10,697 units every 12 days since 2019. As of 27 May 2021 she still owns at least 7,501 units of Moderna Inc stock.
You can see the complete history of Ms. Henderson stock trades at the bottom of the page.
Lori Henderson J.D. serves as General Counsel, Company Secretary of the Company. From 2011 to 2018, Ms. Henderson served at Albany Molecular Research Inc. (Nasdaq: AMRI) first as Vice President, General Counsel and Corporate Secretary until 2014 and then as Senior Vice President, General Counsel and Head of Business Development. Prior to her time at AMRI, Ms. Henderson worked as a corporate attorney at Goodwin Procter LLP and as a General Counsel at other corporations. She received her J.D. from the George Washington University Law School and her B.A. in Business and Economics from Gordon College.
Lori Henderson is 58, she's been the General Counsel e Company Secretary of Moderna Inc since 2018. There are 5 older and 11 younger executives at Moderna Inc. The oldest executive at Moderna Inc is Elizabeth Tallett, 71, who is the Director.
Lori's mailing address filed with the SEC is 26 Corporate Cir, Albany, NY 12203, USA.
Over the last 6 years, insiders at Moderna Inc have traded over $2,713,086,305 worth of Moderna Inc stock and bought 52,631 units worth $999,989 . The most active insiders traders include Noubar Afeyan, David M. Rubenstein, eStephane Bancel. On average, Moderna Inc executives and independent directors trade stock every 2 days with the average trade being worth of $2,841,687. The most recent stock trade was executed by Shannon Thyme Klinger on 6 September 2024, trading 1,139 units of MRNA stock currently worth $90,562.
moderna is pioneering messenger rna therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. this breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions. moderna has developed a broad intellectual property estate including more than 200 patent applications with more than 10,000 claims ranging from novel nucleotide chemistries to specific drug compositions. the company plans to develop and commercialize its innovative mrna drugs—initially for rare diseases and oncology—while partnering drug candidates in other therapeutics areas in order to rapidly deliver this innovation to patients. based in cambridge, massachusetts, moderna is privately held and was founded in 2010 by flagship venturelabs in association with leading scientists from boston children’s hospital a
Moderna Inc executives and other stock owners filed with the SEC include: